Cancer Market Research Reports & Industry Analysis
Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
... markets for novel products, diagnostics and therapeutics development. The report covers the regulatory environment, current and new technologies, ovarian cancer incidence, market projections and market ... covers global and regional markets for ovarian cancer diagnostics and therapies, providing reasons for ...
Apr, 2018 168 pages... maintained a relatively optimistic growth, the past four years, Peptide Cancer Vaccine market size to maintain the average annual growth rate of ... next few years, Peptide Cancer Vaccine market size will be further expanded, we expect that by 2022, The market size of the Peptide Cancer Vaccine will reach 650 ...
Apr, 2018 118 pages... maintained a relatively optimistic growth, the past four years, Breast Cancer Screening market size to maintain the average annual growth rate of ... next few years, Breast Cancer Screening market size will be further expanded, we expect that by 2022, The market size of the Breast Cancer Screening will reach xxx ...
Apr, 2018 120 pages... option. According to the RNCOS report entitled “Promising Outlook - US Cancer Vaccine Market”, the US is largest market for cancer vaccines amongst all the geographic regions ... has been segmented into three types, namely, liver cancer, HPV related cancer, and others. On the basis of type of vaccine, the market ...
Apr, 2018 135 pages... License depending on the location. “US Breast Cancer Lumpectomy Market, Treatment Cost & Opportunity Analysis 2024” Report Highlights: Lumpectomy Procedure & Cost Involved Lumpectomy & Mastectomy Reimbursement Analysis Lumpectomy Market Analysis by Technology Presence of Venture ...
Mar, 2018 100 pagesNon-Small Cell Lung Cancer (NSCLC) - Dynamic Market Forecast to 2025 SUMMARY The NSCLC therapeutics market is a rapidly evolving field in which new developments ... designed to help clients stay abreast of the latest news in the NSCLC space, including regulatory, commercial, and clinical events, and to understand ...
Aug, 2017 65 pages... patients with newly diagnosed, high-risk, metastatic hormone-sensitive prostate cancer (mHSPC); Bavarian Nordic’s announcement that it was discontinuing ... Xofigo (radium-223 dichloride) in combination with J&J's Zytiga in patients with prostate cancer as a result of an imbalance of more fractures and deaths in ...
Jan, 2018... ) from North America and Europe on a variety of recent events in the colorectal cancer (CRC) market, including; Symphogen announcing detailed results from its ...
Dec, 2017This study covers the world outlook for oncology based molecular diagnostics across more than 190 countries. For each year reported ... demand, or the P.I.E., for oncology based molecular diagnostics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also ...
Jan, 2018 269 pagesThis study covers the world outlook for lung cancer diagnostics across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for lung cancer diagnostics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
Jan, 2018 268 pagesThis study covers the world outlook for in-vitro colorectal cancer screening tests across more than 190 countries. For each year ... demand, or the P.I.E., for in-vitro colorectal cancer screening tests. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I ...
Jan, 2018 271 pages... study covers the world outlook for cervical cancer diagnostics across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for cervical cancer diagnostics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
Jan, 2018 268 pagesThis study covers the world outlook for cancer supportive care products across more than 190 countries. For each year reported, ... latent demand, or the P.I.E., for cancer supportive care products. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also ...
Jan, 2018 268 pagesThis study covers the world outlook for cancer care genomics across more than ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for cancer care genomics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
Jan, 2018 268 pages... specific opportunities and growth strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field ...
Mar, 2018 1450 pages... specific opportunities and growth strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field ...
Mar, 2018 935 pages... ; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...
Mar, 2018 1200 pages... ; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...
Mar, 2018 820 pages... cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market ... the disease. During the next five years, the cancer diagnostics market is promising to be an exciting, dynamic and ...
Mar, 2018 535 pages... Assessment of latest technologies and their potential applications for cancer diagnostic testing. Review of competing/complementing technologies. Companies, ... universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Strategies Strategic ...
Mar, 2018 630 pages... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) development landscape Develop ...
Feb, 2018 77 pages... Cancer Immunotherapy market Market status and development trend of Cancer Immunotherapy by types and applications Cost and profit status of Cancer Immunotherapy, and marketing status Market growth drivers and challenges The report segments the United States Cancer Immunotherapy market as: United States Cancer ...
Feb, 2018 138 pages... Cancer Immunotherapy market Market status and development trend of Cancer Immunotherapy by types and applications Cost and profit status of Cancer Immunotherapy, and marketing status Market growth drivers and challenges The report segments the South America Cancer Immunotherapy market as: South America Cancer ...
Feb, 2018 159 pages... Cancer Immunotherapy market Market status and development trend of Cancer Immunotherapy by types and applications Cost and profit status of Cancer Immunotherapy, and marketing status Market growth drivers and challenges The report segments the North America Cancer Immunotherapy market as: North America Cancer ...
Feb, 2018 157 pages... Cancer Immunotherapy market Market status and development trend of Cancer Immunotherapy by types and applications Cost and profit status of Cancer Immunotherapy, and marketing status Market growth drivers and challenges The report segments the India Cancer Immunotherapy market as: India Cancer Immunotherapy ...
Feb, 2018 145 pagesReport Summary Cancer Immunotherapy-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cancer Immunotherapy industry, standing on the readers’ perspective, delivering detailed market data and ...
Feb, 2018 147 pages... Cancer Immunotherapy-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Cancer Immunotherapy industry, standing on the readers’ perspective, delivering detailed market data in Global ...
Feb, 2018 160 pages... Cancer Immunotherapy market Market status and development trend of Cancer Immunotherapy by types and applications Cost and profit status of Cancer Immunotherapy, and marketing status Market growth drivers and challenges The report segments the Europe Cancer Immunotherapy market as: Europe Cancer Immunotherapy ...
Feb, 2018 151 pagesReport Summary Cancer Immunotherapy-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cancer Immunotherapy industry, standing on the readers’ perspective, delivering detailed market data and ...
Feb, 2018 148 pages... Cancer Immunotherapy market Market status and development trend of Cancer Immunotherapy by types and applications Cost and profit status of Cancer Immunotherapy, and marketing status Market growth drivers and challenges The report segments the China Cancer Immunotherapy market as: China Cancer Immunotherapy ...
Feb, 2018 149 pages... Cancer Immunotherapy market Market status and development trend of Cancer Immunotherapy by types and applications Cost and profit status of Cancer Immunotherapy, and marketing status Market growth drivers and challenges The report segments the Asia Pacific Cancer Immunotherapy market as: Asia Pacific Cancer ...
Feb, 2018 153 pages... maintained a relatively optimistic growth, the past four years, Oncolytic Virus Therapy market size to maintain the average annual growth rate of ... next few years, Oncolytic Virus Therapy market size will be further expanded, we expect that by 2022, The market size of the Oncolytic Virus Therapy will reach XXXX ...
Feb, 2018 124 pages... other cancer treating drugs. Cancer Monoclonal Antibodies Market Outline The market growth of cancer monoclonal antibodies is driven by increased prevalence of cancer worldwide. According to WHO, cancer is one of the leading cause of deaths worldwide. In 2012 ...
Jan, 2018 188 pages